University of Birmingham-ko ikertzaileekin lankidetzan egindako argitalpenak (2)

2017

  1. The MAGIC survey in hormone receptor positive (HR+), HER2-negative (HER2−) breast cancer: When might multigene assays be of value?

    Breast, Vol. 33, pp. 191-199

2015

  1. Aromatase inhibitors versus tamoxifen in early breast cancer: Patient-level meta-analysis of the randomised trials

    The Lancet, Vol. 386, Núm. 10001, pp. 1341-1352